OverviewSuggest Edit

Fibrocell Science is an autologous cell and gene therapy company, focusing on discovering and developing therapies for diseases affecting the skin, connective tissues and joints. The Company’s gene-therapy product candidates include FCX-007 that is in Phase I/II clinical trials to treat recessive dystrophic epidermolysis bullosa; FCX-013, which is in pre-clinical development stage for the treatment of linear scleroderma; and gene-therapy program that is in research phase to arthritis and related conditions.

TypePublic
Founded1995
HQExton, US
Websitefibrocell.com

Latest Updates

Employees (est.) (Dec 2018)19(-5%)
Revenue (FY, 2018)$0
Share Price (Dec 2019)$3
Cybersecurity ratingAMore

Key People/Management at Fibrocell Science

John Maslowski

John Maslowski

President and Chief Executive Officer
Pamela Swiggard

Pamela Swiggard

Vice President of Regulatory Affairs and Quality Assurance
Sean Buckley

Sean Buckley

Vice President of Business Administration and Corporate Secretary
Show more

Fibrocell Science Office Locations

Fibrocell Science has an office in Exton
Exton, US (HQ)
405 Eagleview Blvd
Show all (1)

Fibrocell Science Financials and Metrics

Fibrocell Science Revenue

USD

Revenue (Q3, 2019)

1.0m

Gross profit (Q3, 2019)

(667.0k)

Gross profit margin (Q3, 2019), %

(65.5%)

Net income (Q3, 2019)

(7.2m)

EBIT (Q3, 2019)

(4.4m)

Market capitalization (12-Dec-2019)

29.3m

Closing stock price (12-Dec-2019)

3.0

Cash (30-Sept-2019)

6.8m

EV

27.5m
Fibrocell Science's current market capitalization is $29.3 m.
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

153.0k200.0k180.0k492.0k355.0k

Revenue growth, %

(10%)173%(28%)

Cost of goods sold

8.4m8.1m2.3m722.0k697.0k

Gross profit

(8.2m)(7.9m)(2.1m)(230.0k)(342.0k)
Quarterly
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

10.8m31.3m60.0m37.5m29.3m17.5m17.4m14.4m

Accounts Receivable

215.7k62.0k28.0k4.0k

Prepaid Expenses

1.2m1.3m1.2m1.3m1.2m485.0k105.0k

Inventories

266.3k477.0k597.0k571.0k482.0k
USDQ2, 2011

Debt/Equity

-0.3 x

Debt/Assets

0.7 x

Financial Leverage

-0.4 x
Show all financial metrics

Fibrocell Science Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Fibrocell Science Online and Social Media Presence

Embed Graph

Fibrocell Science Frequently Asked Questions

  • When was Fibrocell Science founded?

    Fibrocell Science was founded in 1995.

  • Who are Fibrocell Science key executives?

    Fibrocell Science's key executives are John Maslowski, Pamela Swiggard and Sean Buckley.

  • How many employees does Fibrocell Science have?

    Fibrocell Science has 19 employees.

  • Who are Fibrocell Science competitors?

    Competitors of Fibrocell Science include BioSpecifics Technologies, Gilead Sciences and Adagene.

  • Where is Fibrocell Science headquarters?

    Fibrocell Science headquarters is located at 405 Eagleview Blvd, Exton.

  • Where are Fibrocell Science offices?

    Fibrocell Science has an office in Exton.

  • How many offices does Fibrocell Science have?

    Fibrocell Science has 1 office.